483 related articles for article (PubMed ID: 12124824)
21. Endocrine response after gamma knife-based stereotactic radiosurgery for secretory pituitary adenoma.
Tinnel BA; Henderson MA; Witt TC; Fakiris AJ; Worth RM; Des Rosiers PM; Edmondson JW; Timmerman RD; Lo SS
Stereotact Funct Neurosurg; 2008; 86(5):292-6. PubMed ID: 18758206
[TBL] [Abstract][Full Text] [Related]
22. [The relationship between cell proliferation activity and secretory activity in pituitary adenoma--a review of 63 cases].
Asano K; Kubo O; Tajika Y; Huang MC; Takakura K
No To Shinkei; 1996 Jun; 48(6):543-9. PubMed ID: 8703557
[TBL] [Abstract][Full Text] [Related]
23. [Melatonin inhibits the proliferation of pituitary prolactin-secreting tumor by suppressing the enhancer elements mutation of PRL gene in the rat].
Gao L; Yang QH; Xu RK
Sheng Li Xue Bao; 2005 Jun; 57(3):319-27. PubMed ID: 15968426
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical analysis of tumor angiogenic factors in human pituitary adenomas.
Niveiro M; Aranda FI; Peiró G; Alenda C; Picó A
Hum Pathol; 2005 Oct; 36(10):1090-5. PubMed ID: 16226108
[TBL] [Abstract][Full Text] [Related]
25. Pathological study of thyrotropin-secreting pituitary adenoma: plurihormonality and medical treatment.
Teramoto A; Sanno N; Tahara S; Osamura YR
Acta Neuropathol; 2004 Aug; 108(2):147-53. PubMed ID: 15185102
[TBL] [Abstract][Full Text] [Related]
26. Giant invasive prolactinoma: a case report and review of nine further cases.
Davis JR; Sheppard MC; Heath DA
Q J Med; 1990 Mar; 74(275):227-38. PubMed ID: 2385731
[TBL] [Abstract][Full Text] [Related]
27. [Prolactin producing adenoma].
Tamaki N; Yonezawa K
Nihon Rinsho; 1993 Oct; 51(10):2685-90. PubMed ID: 8254940
[TBL] [Abstract][Full Text] [Related]
28. High Ki-67 expression is associated with prolactin secreting pituitary adenomas.
Bălinişteanu B; Cîmpean AM; Ceauşu AR; Corlan AS; Melnic E; Raica M
Bosn J Basic Med Sci; 2017 May; 17(2):104-108. PubMed ID: 28432860
[TBL] [Abstract][Full Text] [Related]
29. Topoisomerase IIalpha expression in pituitary adenomas and carcinomas: relationship to tumor behavior.
Vidal S; Kovacs K; Horvath E; Rotondo F; Kuroki T; Lloyd RV; Scheithauer BW
Mod Pathol; 2002 Nov; 15(11):1205-12. PubMed ID: 12429800
[TBL] [Abstract][Full Text] [Related]
30. Detection of mammosomatotrophs in paraffin-embedded specimens of various pituitary adenomas.
Huang MC; Kubo O; Tajika Y; Cheng H; Huang CI; Lee LS; Takakura K
Zhonghua Yi Xue Za Zhi (Taipei); 1999 Dec; 62(12):845-51. PubMed ID: 10633997
[TBL] [Abstract][Full Text] [Related]
31. Pituitary adenomas treated with gamma knife radiosurgery: volumetric analysis of 100 cases with minimum 3 year follow-up.
Pamir MN; Kiliç T; Belirgen M; Abacioğlu U; Karabekiroğlu N
Neurosurgery; 2007 Aug; 61(2):270-80; discussion 280. PubMed ID: 17762739
[TBL] [Abstract][Full Text] [Related]
32. A clinical study of the pineal hormone melatonin in patients with growth hormone or prolactin secreting pituitary tumours.
Lissoni P; Mainini E; Rovelli F; Mazzi C; Ardizzoia A; Gelosa M; Capra M; Rivolta MR
Eur J Med; 1992 Nov; 1(7):407-10. PubMed ID: 1341480
[TBL] [Abstract][Full Text] [Related]
33. Endoscopic transsphenoidal treatment of hormonally active pituitary adenomas.
Rudnik A; Kos-Kudła B; Larysz D; Zawadzki T; Bazowski P
Neuro Endocrinol Lett; 2007 Aug; 28(4):438-44. PubMed ID: 17693972
[TBL] [Abstract][Full Text] [Related]
34. [Inhibitory effects of melatonin on the development of 17-beta-estradiol induced prolactinoma in relation to plasma prolactin and peroxidative lipid contents].
Gao L; Xu JP; Shan HM; Zhang R; Xu RK
Sheng Li Xue Bao; 2001 Jun; 53(3):165-9. PubMed ID: 12589398
[TBL] [Abstract][Full Text] [Related]
35. Hormonal evidence for the dissemination through the cerebrospinal fluid, of secreting cells from invasive pituitary adenomas.
Coculescu M; Temel E; Oprescu M; Constantinovici A; Carp N; Simiónescu N
Endocrinologie; 1981; 19(2):129-35. PubMed ID: 7256167
[TBL] [Abstract][Full Text] [Related]
36. Identification of somatotrophs, mammosomatotrophs, and mammotrophs by sandwich cell immunoblot assay in GH-secreting adenomas and prolactinomas: correlations between the proportions of hormone secreting cells and tumor size.
Kojima Y; Suzuki S; Yamamura K; Kawasaki T; Yamamoto I
Endocr J; 2000 Apr; 47(2):143-55. PubMed ID: 10943738
[TBL] [Abstract][Full Text] [Related]
37. Hormone production in pituitary adenomas following external irradiation: an experimental study in rats.
Friedrich RE; Saeger W; Laas R; Friedrich SB
Anticancer Res; 2000; 20(6D):5165-70. PubMed ID: 11326689
[TBL] [Abstract][Full Text] [Related]
38. Clinical tumor growth and comparison with proliferation markers in non-functioning (inactive) pituitary adenomas.
Saeger W; Lüdecke B; Lüdecke DK
Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):80-5. PubMed ID: 18072009
[TBL] [Abstract][Full Text] [Related]
39. Morphologic changes of prolactin-producing pituitary adenomas after short treatment with dopamine agonists.
Kontogeorgos G; Horvath E; Kovacs K; Coire C; Lloyd RV; Scheithauer BW; Smyth HS
Acta Neuropathol; 2006 Jan; 111(1):46-52. PubMed ID: 16328513
[TBL] [Abstract][Full Text] [Related]
40. Headache, hyperprolactinemia, and prolactinomas.
Strebel PM; Zacur HA; Gold EB
Obstet Gynecol; 1986 Aug; 68(2):195-9. PubMed ID: 3737035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
